Bridgeway Capital Management’s MacroGenics MGNX Stock Holding History

Bridgeway Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Hold	73,500	–	–	0.01%	948
2026 Q1	$212K	Sell	73,500 -7,700	-9%	-$16.4K	﹤0.01%	1022
2025 Q4	$131K	Sell	81,200 -7,500	-8%	-$11.8K	﹤0.01%	1093
2025 Q3	$149K	Sell	88,700 -45,000	-34%	-$72.8K	﹤0.01%	1055
2025 Q2	$162K	Buy	133,700 +18,500	+16%	+$26.8K	﹤0.01%	1004
2025 Q1	$146K	Buy	115,200 +11,200	+11%	+$29.3K	﹤0.01%	979
2024 Q4	$338K	Buy	+104,000	New	+$375K	0.01%	898

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Bridgeway Capital Management's MGNX Position: Q2 2026 in Review

Bridgeway Capital Management held its MacroGenics (MGNX) position steady in Q2 2026 at 73,500 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #948.

Bridgeway Capital Management first reported a position in MGNX in Q4 2024 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Bridgeway Capital Management held 73,500 shares of MacroGenics worth $340K as of Q2 2026.
Bridgeway Capital Management left its MacroGenics share count unchanged in Q2 2026.
MacroGenics made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #948 holding.
Bridgeway Capital Management first reported a position in MacroGenics in Q4 2024 and has held it in 7 quarters since.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.